PMC9986897_01
Magnetic resonance imaging of the pelvis. T2-weighted sequence, mass dependent on the rectum and superior rectosigmoid junction (orange arrowhead) and dilatation of the inferior rectum (arrow white).
10.1177_2050313X231157483-fig1.jpg
PMC9986897_01_10.1177_2050313X231157483-fig1.jpg
fig1-2050313X231157483
Broad-spectrum antibiotic management was started with piperacillin/tazobactam at a dose of 4.5 g every 6 h, and a nuclear magnetic resonance was taken to rule out tumor involvement versus intra-abdominal collections with the following findings: mass dependent on the rectum and superior rectosigmoid junction (orange arrowhead) and dilatation of the inferior rectum (arrow white) (Figure 1), mass with circumferential, lobulated involvement of sigmoid walls (yellow arrowhead), suspicious lymph nodes and mesorectal lymph nodes (white arrow) (Figure 2), and dilatation of the inferior rectus (white arrow) (Figure 3.)
Magnetic resonance imaging of the pelvis. T2-weighted sequence, identifying a mass with circumferential, lobulated involvement of sigmoid walls (yellow arrowhead) and suspicious lymph nodes and mesorectal lymph nodes (white arrow).
10.1177_2050313X231157483-fig2.jpg
PMC9986897_01_10.1177_2050313X231157483-fig2.jpg
fig2-2050313X231157483
Broad-spectrum antibiotic management was started with piperacillin/tazobactam at a dose of 4.5 g every 6 h, and a nuclear magnetic resonance was taken to rule out tumor involvement versus intra-abdominal collections with the following findings: mass dependent on the rectum and superior rectosigmoid junction (orange arrowhead) and dilatation of the inferior rectum (arrow white) (Figure 1), mass with circumferential, lobulated involvement of sigmoid walls (yellow arrowhead), suspicious lymph nodes and mesorectal lymph nodes (white arrow) (Figure 2), and dilatation of the inferior rectus (white arrow) (Figure 3.)
Magnetic resonance imaging of the pelvis, T2-weighted sequence shows dilatation of the inferior rectus (white arrow).
10.1177_2050313X231157483-fig3.jpg
PMC9986897_01_10.1177_2050313X231157483-fig3.jpg
fig3-2050313X231157483
Broad-spectrum antibiotic management was started with piperacillin/tazobactam at a dose of 4.5 g every 6 h, and a nuclear magnetic resonance was taken to rule out tumor involvement versus intra-abdominal collections with the following findings: mass dependent on the rectum and superior rectosigmoid junction (orange arrowhead) and dilatation of the inferior rectum (arrow white) (Figure 1), mass with circumferential, lobulated involvement of sigmoid walls (yellow arrowhead), suspicious lymph nodes and mesorectal lymph nodes (white arrow) (Figure 2), and dilatation of the inferior rectus (white arrow) (Figure 3.)